Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Jan;84(2):561–563. doi: 10.1073/pnas.84.2.561

Left globus pallidus abnormality in never-medicated patients with schizophrenia.

T S Early, E M Reiman, M E Raichle, E L Spitznagel
PMCID: PMC304249  PMID: 3467374

Abstract

Schizophrenia is a severe psychiatric disorder characterized by onset in young adulthood, the occurrence of hallucinations and delusions, and the development of enduring psychosocial disability. The pathophysiology of this disorder remains unknown. Studies of cerebral blood flow and metabolism designed to identify brain abnormalities in schizophrenia have been limited by inadequate methods of anatomical localization and the possibility of persistent medication effects. We have now used positron emission tomography and a validated method of anatomical localization in an attempt to identify abnormalities of regional cerebral blood flow in newly diagnosed never-medicated patients with schizophrenia. An exploratory study of 5 patients and 10 normal control subjects identified abnormally high blood flow in the left globus pallidus of patients with schizophrenia. A replication study of 5 additional patients and 10 additional control subjects confirmed this finding. No other abnormalities were found.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariel R. N., Golden C. J., Berg R. A., Quaife M. A., Dirksen J. W., Forsell T., Wilson J., Graber B. Regional cerebral blood flow in schizophrenics. Tests using the xenon Xe 133 inhalation method. Arch Gen Psychiatry. 1983 Mar;40(3):258–263. doi: 10.1001/archpsyc.1983.01790030028003. [DOI] [PubMed] [Google Scholar]
  2. Berman K. F., Zec R. F., Weinberger D. R. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry. 1986 Feb;43(2):126–135. doi: 10.1001/archpsyc.1986.01800020032005. [DOI] [PubMed] [Google Scholar]
  3. Buchsbaum M. S., DeLisi L. E., Holcomb H. H., Cappelletti J., King A. C., Johnson J., Hazlett E., Dowling-Zimmerman S., Post R. M., Morihisa J. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry. 1984 Dec;41(12):1159–1166. doi: 10.1001/archpsyc.1984.01790230045007. [DOI] [PubMed] [Google Scholar]
  4. Buchsbaum M. S., Ingvar D. H., Kessler R., Waters R. N., Cappelletti J., van Kammen D. P., King A. C., Johnson J. L., Manning R. G., Flynn R. W. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry. 1982 Mar;39(3):251–259. doi: 10.1001/archpsyc.1982.04290030001001. [DOI] [PubMed] [Google Scholar]
  5. Campbell A., Baldessarini R. J., Teicher M. H., Kula N. S. Prolonged antidopaminergic actions of single doses of butyrophenones in the rat. Psychopharmacology (Berl) 1985;87(2):161–166. doi: 10.1007/BF00431801. [DOI] [PubMed] [Google Scholar]
  6. Crow T. J., Deakin J. F., Longden A. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs? Psychol Med. 1977 May;7(2):213–221. doi: 10.1017/s0033291700029287. [DOI] [PubMed] [Google Scholar]
  7. DeLisi L. E., Holcomb H. H., Cohen R. M., Pickar D., Carpenter W., Morihisa J. M., King A. C., Kessler R., Buchsbaum M. S. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab. 1985 Jun;5(2):201–206. doi: 10.1038/jcbfm.1985.26. [DOI] [PubMed] [Google Scholar]
  8. Dray A. The physiology and pharmacology of mammalian basal ganglia. Prog Neurobiol. 1980;14(4):221–335. doi: 10.1016/0301-0082(80)90017-9. [DOI] [PubMed] [Google Scholar]
  9. Farkas T., Wolf A. P., Jaeger J., Brodie J. D., Christman D. R., Fowler J. S. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry. 1984 Mar;41(3):293–300. doi: 10.1001/archpsyc.1984.01790140083010. [DOI] [PubMed] [Google Scholar]
  10. Fox P. T., Perlmutter J. S., Raichle M. E. A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr. 1985 Jan-Feb;9(1):141–153. doi: 10.1097/00004728-198501000-00025. [DOI] [PubMed] [Google Scholar]
  11. Fox P. T., Raichle M. E. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1140–1144. doi: 10.1073/pnas.83.4.1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Franzén G., Ingvar D. H. Absence of activation in frontal structures during psychological testing of chronic schizophrenics. J Neurol Neurosurg Psychiatry. 1975 Oct;38(10):1027–1032. doi: 10.1136/jnnp.38.10.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gur R. E., Gur R. C., Skolnick B. E., Caroff S., Obrist W. D., Resnick S., Reivich M. Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry. 1985 Apr;42(4):329–334. doi: 10.1001/archpsyc.1985.01790270015001. [DOI] [PubMed] [Google Scholar]
  14. Gur R. E., Skolnick B. E., Gur R. C., Caroff S., Rieger W., Obrist W. D., Younkin D., Reivich M. Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry. 1983 Nov;40(11):1250–1254. doi: 10.1001/archpsyc.1983.01790100096013. [DOI] [PubMed] [Google Scholar]
  15. Herscovitch P., Markham J., Raichle M. E. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med. 1983 Sep;24(9):782–789. [PubMed] [Google Scholar]
  16. Ingvar D. H., Franzén G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974;50(4):425–462. doi: 10.1111/j.1600-0447.1974.tb09707.x. [DOI] [PubMed] [Google Scholar]
  17. Ingvar D. H., Franzén G. Distribution of cerebral activity in chronic schizophrenia. Lancet. 1974 Dec 21;2(7895):1484–1486. doi: 10.1016/s0140-6736(74)90221-9. [DOI] [PubMed] [Google Scholar]
  18. Mathew R. J., Duncan G. C., Weinman M. L., Barr D. L. Regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry. 1982 Oct;39(10):1121–1124. doi: 10.1001/archpsyc.1982.04290100001001. [DOI] [PubMed] [Google Scholar]
  19. Newlin D. B., Carpenter B., Golden C. J. Hemispheric asymmetries in schizophrenia. Biol Psychiatry. 1981 Jun;16(6):561–582. [PubMed] [Google Scholar]
  20. Perlmutter J. S., Herscovitch P., Powers W. J., Fox P. T., Raichle M. E. Standardized mean regional method for calculating global positron emission tomographic measurements. J Cereb Blood Flow Metab. 1985 Sep;5(3):476–480. doi: 10.1038/jcbfm.1985.66. [DOI] [PubMed] [Google Scholar]
  21. Perlmutter J. S., Raichle M. E. Regional blood flow in hemiparkinsonism. Neurology. 1985 Aug;35(8):1127–1134. doi: 10.1212/wnl.35.8.1127. [DOI] [PubMed] [Google Scholar]
  22. Raichle M. E., Grubb R. L., Jr, Gado M. H., Eichling J. O., Ter-Pogossian M. M. Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man. Arch Neurol. 1976 Aug;33(8):523–526. doi: 10.1001/archneur.1976.00500080001001. [DOI] [PubMed] [Google Scholar]
  23. Raichle M. E., Martin W. R., Herscovitch P., Mintun M. A., Markham J. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med. 1983 Sep;24(9):790–798. [PubMed] [Google Scholar]
  24. Schwartz W. J., Smith C. B., Davidsen L., Savaki H., Sokoloff L., Mata M., Fink D. J., Gainer H. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science. 1979 Aug 17;205(4407):723–725. doi: 10.1126/science.462184. [DOI] [PubMed] [Google Scholar]
  25. Sheppard G., Gruzelier J., Manchanda R., Hirsch S. R., Wise R., Frackowiak R., Jones T. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet. 1983 Dec 24;2(8365-66):1448–1452. doi: 10.1016/s0140-6736(83)90798-5. [DOI] [PubMed] [Google Scholar]
  26. Stevens J. R. An anatomy of schizophrenia? Arch Gen Psychiatry. 1973 Aug;29(2):177–189. doi: 10.1001/archpsyc.1973.04200020023003. [DOI] [PubMed] [Google Scholar]
  27. Ter-Pogossian M. M., Ficke D. C., Hood J. T., Sr, Yamamoto M., Mullani N. A. PETT VI: a positron emission tomograph utilizing cesium fluoride scintillation detectors. J Comput Assist Tomogr. 1982 Feb;6(1):125–133. [PubMed] [Google Scholar]
  28. Volkow N. D., Brodie J. D., Wolf A. P., Angrist B., Russell J., Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1199–1202. doi: 10.1136/jnnp.49.10.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weinberger D. R., Berman K. F., Zec R. F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry. 1986 Feb;43(2):114–124. doi: 10.1001/archpsyc.1986.01800020020004. [DOI] [PubMed] [Google Scholar]
  30. Widen L., Blomqvist G., Greitz T., Litton J. E., Bergström M., Ehrin E., Ericson K., Eriksson L., Ingvar D. H., Johansson L. PET studies of glucose metabolism in patients with schizophrenia. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):550–552. [PMC free article] [PubMed] [Google Scholar]
  31. Wolkin A., Jaeger J., Brodie J. D., Wolf A. P., Fowler J., Rotrosen J., Gomez-Mont F., Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry. 1985 May;142(5):564–571. doi: 10.1176/ajp.142.5.564. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES